U.S. Markets open in 2 hrs.

GlycoMimetics, Inc. (GLYC)

NASDAQ Global Market - NASDAQ Global Market Delayed Price. Currency in USD
Add to watchlist
10.53+0.32 (+3.13%)
At close: 4:00PM EDT
People also watch
AKBAGNCADRNALOXOAKAO
  • E
    Elizabeth
    Elizabeth
    I think GLYC is due for a pullback. What are your thoughts? have you guys heard of awe-some*sto-cks. i started receiving their allerts and so far i am happy.
  • h
    hong
    hong
    What's going on?
  • A
    Arnold
    Arnold
    What is going on here. Durign the day, the price drops to low 11, an after hours it goes 1 dollar up. and it's another day in a row
  • M
    Mary
    Mary
    GLYC, looks to be overvalued at this price google awesome_stock.s - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
  • w
    woofpack17
    woofpack17

    Interesting. . . I posted a link related to GLYC's development and lead candidate earlier, but it seems to have been deleted. Surely no censorship on an open message board!

    I'll post it again, no biggie. My legitimate question for this board is as follows: Does Midostaurin pose a threat to GLYC's GMI-1271? Here is a link to the story. . . and I hope "yahoo" does not strike down a legitimate and possibly serious concern for traders and investors on this board. If someone can give me an educated answer. I will let it go, but keep posting it otherwise.

    http://www.cancernetwork.com/news/midostaurin-improves-survival-flt3-mutant-aml?GUID=5AA0E0A6-23D8-45B2-AE83-2859B92B830C&XGUID=&rememberme=1&ts=23062017

    Midostaurin Improves Survival in FLT3-Mutant AML | Cancer Network
    Adding midostaurin to chemotherapy prolonged survival in younger adult patients with acute myeloid leukemia and a FLT3 mutation, according to a randomized trial.
    www.cancernetwork.com
  • 2
    20 Miles
    20 Miles
    out 13.45! Happy happy!
  • w
    woofpack17
    woofpack17
    Looks like time to dump this puppy and take profits ASAP!
  • A
    Arnold
    Arnold
    id it breaks 12 50 then next stop should be 13-13 50 and then next around 16
  • L
    Leon
    Leon
    Damn my limit order kicked in a lil bit too soon today, big block trade late this afternoon, does anyone know why?
  • D
    Day B
    Day B
    Where is the volume? MM's trading to themselves @ 100 blocks trying desperately to create a market for this POS. Big Short buying at end of bell. Volume slowly going back under 100K per day.
  • M
    My Team
    My Team
    long TGTX
  • A
    Arnold
    Arnold

    https://seekingalpha.com/article/4081342-glycomimetics-remains-undervalued-leukemia-trial-news

    GlycoMimetics Remains Undervalued After Leukemia Trial News
    Based on its clinical pipeline, GlycoMimetics has long been undervalued. The announcement of strong AML trial data on May 18 moved the stock higher. Rivipansel
    seekingalpha.com
  • G
    Graciela
    Graciela

    Thanks for the tip, I did some research and found more information about $GLYC on http://wefunder.com/bchi/?s=GLYC "hhse" Day trading trading stocks.

    Invest in Buying Collective Holdings Inc. | Organic, non-GMO foods at wholesale prices, delivered to your doorstep on @wefunder
    We're focused on (1) building the Buying Collective of CLEAN food shoppers through the Health Merchant® network; (2) sourcing CLEAN foods at the lowest possible cost; and (3) selling CLEAN foods with direct, free delivery to households that are part
    wefunder.com
  • 2
    20 Miles
    20 Miles
    Did I read this report wrong? why is this thing getting hammered today? I thought update was good news??
  • A
    Atsushi
    Atsushi
    $25 per share! Easy buy-out for GILD or Amgen!

    strong pipeline drugs! The earning per share will sharply rise soon!
  • l
    leo
    leo
    wow $16 up!!!!!
  • C
    Carl
    Carl

    CEO and Co-Founder Rachel K. King recently did a long interview, worth a look.

    “We have basically taken the technology around how to rationally design what we call glycomimetic molecules and now have applied that to several diseases in the hematology space.”

    https://www.twst.com/interview/interview-with-the-co-founder-and-ceo-glycomimetics-inc

    Interview with the Co-Founder and CEO: GlycoMimetics, Inc. (NASDAQ:GLYC) - The Wall Street Transcript
    TWST: Can you briefly describe what the company is and describe its core technology? Mrs. King: The core technology enables us to target carbohydrate-related mechanisms of disease with small molecules, and we have applied that to several disease targ
    www.twst.com
  • L
    Latasha
    Latasha
    The upside potential for GLYC just got a whole lot more interesting. Im not sure about you guys but awe.some.stock.s has provided me with some pretty good trade ideas. I messed up executing some of them but thats on me.
  • D
    Day B
    Day B
    Buy on RUMOR....Sell on FAKE NEWS!. No volume - big boys are gone. Wait for
    next new round of funding with millions of more shares just to keep afloat.
  • D
    Daniel
    Daniel
    Another HTGM in the making?